
Aframend is a biotech startup revolutionizing drug discovery through an AI-driven platform. They offer services in compound screening, molecular docking, and dynamics simulations, alongside personalized medicine recommendations and educational courses on AI in drug discovery. Their focus is on accelerating the development of targeted treatments for diseases with a global and African focus, empowering researchers, healthcare providers, and students with essential tools and knowledge.

Aframend is a biotech startup revolutionizing drug discovery through an AI-driven platform. They offer services in compound screening, molecular docking, and dynamics simulations, alongside personalized medicine recommendations and educational courses on AI in drug discovery. Their focus is on accelerating the development of targeted treatments for diseases with a global and African focus, empowering researchers, healthcare providers, and students with essential tools and knowledge.